{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:58:48Z","timestamp":1787165928111,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","academicradiology.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.acra.2024.09.043","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T15:53:18Z","timestamp":1728143598000},"page":"834-843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparative Analysis of Amide Proton Transfer and Diffusionweighted Imaging for Assessing Ki-67, p53 and PD-L1 Expression in Bladder Cancer"],"prefix":"10.1016","volume":"32","author":[{"given":"Jing-Lu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Sheng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Jun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.acra.2024.09.043_bib1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/diagnostics12030586","article-title":"Modified glasgow prognostic score as a predictor of recurrence in patients with high grade non-muscle invasive bladder cancer undergoing intravesical bacillus calmette\u2013guerin immunotherapy","volume":"12","author":"Ferro","year":"2022","journal-title":"Diagnostics"},{"issue":"3","key":"10.1016\/j.acra.2024.09.043_bib2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/jpm13030512","article-title":"Bladder cancer and risk factors: data from a multi-institutional long-term analysis on cardiovascular disease and cancer incidence","volume":"13","author":"Barone","year":"2023","journal-title":"J Pers Med"},{"issue":"10364","key":"10.1016\/j.acra.2024.09.043_bib3","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comp\u00e9rat","year":"2022","journal-title":"The Lancet"},{"issue":"19","key":"10.1016\/j.acra.2024.09.043_bib4","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.acra.2024.09.043_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/JU.0000000000000794","article-title":"Plasmacytoid variant urothelial carcinoma of the bladder: a systematic review and meta-analysis of clinicopathological features and survival outcomes","volume":"204","author":"Kim","year":"2020","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.acra.2024.09.043_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.critrevonc.2013.08.008","article-title":"Biomarkers in bladder cancer: translational and clinical implications","volume":"89","author":"Cheng","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.acra.2024.09.043_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.eururo.2013.03.043","article-title":"Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy","volume":"64","author":"Lotan","year":"2013","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.acra.2024.09.043_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/jnci\/djn451","article-title":"Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer","volume":"101","author":"Margulis","year":"2009","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.acra.2024.09.043_bib9","doi-asserted-by":"crossref","DOI":"10.4081\/ejh.2020.3098","article-title":"Expression of E-cadherin, Ki-67, and p53 in urinary bladder cancer in relation to progression, survival, and recurrence","volume":"64","author":"Ziaran","year":"2020","journal-title":"Eur J Histochem"},{"issue":"8","key":"10.1016\/j.acra.2024.09.043_bib10","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1158\/1078-0432.CCR-18-3147","article-title":"Mutational analysis of 472 urothelial carcinoma across grades and anatomic sites","volume":"25","author":"Nassar","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.acra.2024.09.043_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eururo.2005.12.041","article-title":"The predictive value of p53, p27Kip1, and \u03b1-catenin for progression in superficial bladder carcinoma","volume":"50","author":"Schrier","year":"2006","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.acra.2024.09.043_bib12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/01.ju.0000056085.58221.80","article-title":"The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer","volume":"169","author":"Smith","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.acra.2024.09.043_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.590618","article-title":"A TP53-associated immune prognostic signature for the prediction of overall survival and therapeutic responses in muscle-invasive bladder cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.acra.2024.09.043_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.acra.2024.09.043_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.juro.2016.02.3005","article-title":"Immunotherapy for the treatment of urothelial carcinoma","volume":"197","author":"Donin","year":"2017","journal-title":"J Urol"},{"issue":"19","key":"10.1016\/j.acra.2024.09.043_bib16","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1200\/JCO.2016.71.6795","article-title":"Avelumab, an anti\u2013programmed death-ligand 1 antibody, in patients with refractory metastatic urothelial carcinoma: results from a multicenter, phase Ib study","volume":"35","author":"Apolo","year":"2017","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.acra.2024.09.043_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11604-018-0787-3","article-title":"Amide proton transfer imaging of tumors: theory, clinical applications, pitfalls, and future directions","volume":"37","author":"Kamimura","year":"2019","journal-title":"Jpn J Radiol"},{"issue":"2","key":"10.1016\/j.acra.2024.09.043_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jmri.26645","article-title":"APT-weighted MRI: techniques, current neuro applications, and challenging issues: APTw MRI for neuro applications","volume":"50","author":"Zhou","year":"2019","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.acra.2024.09.043_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1148\/radiol.211804","article-title":"Amide proton transfer-weighted MRI in predicting histologic grade of bladder cancer","volume":"305","author":"Wang","year":"2022","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.acra.2024.09.043_bib20","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1148\/radiol.2018171528","article-title":"Head and neck tumors: amide proton transfer MRI","volume":"288","author":"Law","year":"2018","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.acra.2024.09.043_bib21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.2268","article-title":"Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides","volume":"17","author":"Zhou","year":"2011","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.acra.2024.09.043_bib22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.acra.2023.09.005","article-title":"Amide proton transfer-weighted MRI and diffusion-weighted imaging in bladder cancer: a complementary tool to the VI-RADS","volume":"31","author":"Kong","year":"2024","journal-title":"Acad Radiol"},{"issue":"4","key":"10.1016\/j.acra.2024.09.043_bib23","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.acra.2023.09.044","article-title":"Predicting preoperative pathologic grades of bladder cancer using intravoxel incoherent motion and amide proton transfer-weighted imaging","volume":"31","author":"Chang","year":"2024","journal-title":"Acad Radiol"},{"issue":"24","key":"10.1016\/j.acra.2024.09.043_bib24","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1158\/1078-0432.CCR-06-1472","article-title":"Ki-67 Is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease","volume":"12","author":"Margulis","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.acra.2024.09.043_bib25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.juro.2006.09.038","article-title":"Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma","volume":"177","author":"Shariat","year":"2007","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.acra.2024.09.043_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4097\/kja.21209","article-title":"Receiver operating characteristic curve: overview and practical use for clinicians","volume":"75","author":"Nahm","year":"2022","journal-title":"Korean J Anesthesiol"},{"issue":"5","key":"10.1016\/j.acra.2024.09.043_bib27","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/jmri.27212","article-title":"Comparative analysis of amide proton transfer MRI and diffusion-weighted imaging in assessing p53 and Ki-67 expression of rectal adenocarcinoma","volume":"52","author":"Li","year":"2020","journal-title":"J Magn Reson Imaging"},{"issue":"10","key":"10.1016\/j.acra.2024.09.043_bib28","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1007\/s00330-019-06115-w","article-title":"Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?","volume":"29","author":"Yu","year":"2019","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.acra.2024.09.043_bib29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/neuonc\/not158","article-title":"Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades","volume":"16","author":"Togao","year":"2014","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.acra.2024.09.043_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mri.2018.04.017","article-title":"Amide proton transfer imaging can predict tumor grade in rectal cancer","volume":"51","author":"Nishie","year":"2018","journal-title":"Magn Reson Imaging"},{"issue":"12","key":"10.1016\/j.acra.2024.09.043_bib31","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/3957","article-title":"p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells","volume":"4","author":"Ambs","year":"1998","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.acra.2024.09.043_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40164-022-00297-8","article-title":"Current insight into the regulation of PD-L1 in cancer","volume":"11","author":"Liu","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.acra.2024.09.043_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drup.2019.04.001","article-title":"YY1 regulates cancer cell immune resistance by modulating PD-L1 expression","volume":"43","author":"Hays","year":"2019","journal-title":"Drug Resist Updat"},{"issue":"6","key":"10.1016\/j.acra.2024.09.043_bib34","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2214\/AJR.17.17798","article-title":"DWI as an Imaging Biomarker for Bladder Cancer","volume":"208","author":"Yoshida","year":"2017","journal-title":"Am J Roentgenol"},{"issue":"8","key":"10.1016\/j.acra.2024.09.043_bib35","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1007\/s00330-022-08646-1","article-title":"Soft tissue sarcoma: IVIM and DKI parameters correlate with Ki-67 labeling index on direct comparison of MRI and histopathological slices","volume":"32","author":"Zhang","year":"2022","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.acra.2024.09.043_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13244-019-0771-1","article-title":"Diagnostic value of alternative techniques to gadolinium-based contrast agents in MR neuroimaging\u2014a comprehensive overview.","volume":"10","author":"Falk Delgado","year":"2019","journal-title":"Insights Imaging"},{"issue":"2","key":"10.1016\/j.acra.2024.09.043_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11060-014-1715-8","article-title":"Grading glial tumors with amide proton transfer MR imaging: different analytical approaches","volume":"122","author":"Sakata","year":"2015","journal-title":"J Neurooncol"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633224006925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633224006925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T02:31:10Z","timestamp":1738981870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633224006925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1076633224006925"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2024.09.043","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Analysis of Amide Proton Transfer and Diffusionweighted Imaging for Assessing Ki-67, p53 and PD-L1 Expression in Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2024.09.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Association of Academic Radiology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}